Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 72.15% is in line with its 5-year average of 70.35%, around the middle of its 5-year range (55.77%–81.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.09% above its 12-month average of 68.66%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 72.15%.
DEBT TO ASSETS RATIO
72.15%
DEBT TO ASSETS RATIO AVG TTM
68.66%
DEBT TO ASSETS RATIO AVG 3Y
65.79%
DEBT TO ASSETS RATIO AVG 5Y
70.35%
DEBT TO ASSETS RATIO AVG 10Y
58.85%
DEBT TO ASSETS RATIO AVG 15Y
45.83%
DEBT TO ASSETS RATIO AVG 20Y
35.30%
CURRENT VS TTM AVG
+5.09%
CURRENT VS 3Y AVG
+9.67%
CURRENT VS 5Y AVG
+2.56%
CURRENT VS 10Y AVG
+22.61%
CURRENT VS 15Y AVG
+57.45%
CURRENT VS 20Y AVG
+104.41%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+80069.67%
vs the sector median at left
Harrow Health, Inc.
Market Cap
$1.14B
Debt to Assets Ratio
72.15%
TTM Avg
68.66%
3Y Avg
65.79%
5Y Avg
70.35%
Market Cap
$1.14B
Debt to Assets Ratio
0.39%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.13B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.14B
Debt to Assets Ratio
0.23%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11B
Debt to Assets Ratio
0.64%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.11B
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10B
Debt to Assets Ratio
0.08%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Harrow Health, Inc. (HROW) | $1.14B | 72.15% | 68.66% | 65.79% | 70.35% |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 0.39% | N/A | N/A | N/A |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | 0.04% | N/A | N/A | N/A |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.14B | 0.23% | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | 0.12% | N/A | N/A | N/A |
| Tandem Diabetes Care, Inc. (TNDM)vs › | $1.11B | 0.64% | N/A | N/A | N/A |
| Replimune Group, Inc. (REPL)vs › | $1.11B | 0.44% | N/A | N/A | N/A |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.11B | 0.02% | N/A | N/A | N/A |
| STAAR Surgical Company (STAA)vs › | $1.10B | 0.08% | N/A | N/A | N/A |
| OPKO Health, Inc. (OPK)vs › | $1.09B | 0.21% | N/A | N/A | N/A |
Debt/Assets
72.2%
Debt/Equity
19.79
Current Ratio
2.24
Interest Coverage
1.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 72.15% |
| 2026-03-31 | 71.67% |
| 2025-12-31 | 63.08% |
| 2025-09-30 | 69.37% |
| 2025-06-30 | 67.02% |
| 2025-03-31 | 63.16% |
| 2024-12-31 | 58.83% |
| 2024-09-30 | 55.77% |
| 2024-06-30 | 62.72% |
| 2024-03-31 | 64.85% |
| 2023-12-31 | 61.11% |
| 2023-09-30 | 66.32% |
| 2023-06-30 | 79.21% |
| 2023-03-31 | 81.26% |
| 2022-12-31 | 71.31% |
| 2022-09-30 | 81.28% |
| 2022-06-30 | 81.97% |
| 2022-03-31 | 81.08% |
| 2021-12-31 | 79.28% |
| 2021-09-30 | 74.40% |
| 2021-06-30 | 71.49% |
| 2021-03-31 | 36.93% |
| 2020-12-31 | 40.95% |
| 2020-09-30 | 40.85% |
| 2020-06-30 | 49.05% |
| 2020-03-31 | 44.84% |
| 2019-12-31 | 35.53% |
| 2019-09-30 | 37.02% |
| 2019-06-30 | 31.64% |
| 2019-03-31 | 31.70% |
| 2018-12-31 | 30.83% |
| 2018-09-30 | 54.01% |
| 2018-06-30 | 58.12% |
| 2018-03-31 | 72.26% |
| 2017-12-31 | 64.08% |
| 2017-09-30 | 58.46% |
| 2017-06-30 | 48.60% |
| 2017-03-31 | 53.60% |
| 2016-12-31 | 50.23% |
| 2016-09-30 | 53.92% |
| 2016-06-30 | 42.73% |
| 2016-03-31 | 36.02% |
| 2015-12-31 | 59.15% |
| 2015-09-30 | 54.89% |
| 2015-06-30 | 48.04% |
| 2015-03-31 | 0.42% |
| 2014-12-31 | 0.42% |
| 2014-09-30 | 0.39% |
| 2014-06-30 | 0.12% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-06-30 | 0.00% |
| 2012-03-31 | 271.03% |
| 2011-12-31 | 888.73% |
| 2011-09-30 | 1452.62% |
| 2011-06-30 | 1431.43% |
| 2011-03-31 | 807.46% |
| 2010-12-31 | 299.60% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-09-30 | 0.00% |
| 2009-06-30 | 0.00% |
| 2009-03-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-09-30 | 0.00% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-05-31 | 0.00% |
| 2007-02-28 | 0.00% |
| 2006-11-30 | 0.00% |
| 2006-08-31 | 0.00% |
